Serum 3α-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy

B. J. Reiner, P. A. Donohoue, C. J. Migeon, Gary Berkovitz

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Serum 3α-androstanediol glucuronide (3α-diol G) measurements may indicate the extent of androgen metabolism and action in target tissues. To test this supposition we measured serum 3α-diol G concentrations in 23 women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, including 13 with the salt-losing and 10 with the simple virilizing form, while they were receiving glucocorticoid and, in some cases, mineralocorticoid therapy. Their mean age was 28.3 yr (range, 17.9-38.7 yr). Twenty-four-hour urinary 17-ketosteroid excretion, plasma androstenedione and testosterone levels, and serum 3α-diol G levels were measured during the follicular phase. The values were within or below the normal range in 87%, 78%, 70%, and 91% of the patients, respectively. By contrast, plasma 17-hydroxyprogesterone levels were normal in only 12% of the patients. Serum 3α-diol G levels correlated well with 24-h urinary 17-ketosteroid excretion (r = 0.75) and plasma 17-hydroxyprogesterone (r = 0.77), androstenedione (r = 0.84), and testosterone (r = 0.93) levels. The serum 3α-diol G levels were not significantly different in the women with the salt-losing form and those with the simple virilizing form. However, they were significantly lower (P<0.05) in the women with normal menses compared to those with abnormal menses. This finding underscores the validity of serum 3α-diol G measurements as indicators of androgen production and metabolism in women. The excellent correlation between the serum 3α-diol G levels and standard measures of control indicates that the former measurement may be a useful adjunct in the management of women with congenital adrenal hyperplasia.

Original languageEnglish
Pages (from-to)105-109
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume69
Issue number1
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Congenital Adrenal Hyperplasia
Glucuronides
Serum
17-alpha-Hydroxyprogesterone
17-Ketosteroids
Menstruation
Androstenedione
Plasmas
Metabolism
Therapeutics
Androgens
Testosterone
Salts
Steroid 21-Hydroxylase
Mineralocorticoids
Follicular Phase
Glucocorticoids
Reference Values
Tissue

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Serum 3α-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy. / Reiner, B. J.; Donohoue, P. A.; Migeon, C. J.; Berkovitz, Gary.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 69, No. 1, 01.01.1989, p. 105-109.

Research output: Contribution to journalArticle

@article{a952c84ebe6e4a9d98e69e6e4afdfbb2,
title = "Serum 3α-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy",
abstract = "Serum 3α-androstanediol glucuronide (3α-diol G) measurements may indicate the extent of androgen metabolism and action in target tissues. To test this supposition we measured serum 3α-diol G concentrations in 23 women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, including 13 with the salt-losing and 10 with the simple virilizing form, while they were receiving glucocorticoid and, in some cases, mineralocorticoid therapy. Their mean age was 28.3 yr (range, 17.9-38.7 yr). Twenty-four-hour urinary 17-ketosteroid excretion, plasma androstenedione and testosterone levels, and serum 3α-diol G levels were measured during the follicular phase. The values were within or below the normal range in 87{\%}, 78{\%}, 70{\%}, and 91{\%} of the patients, respectively. By contrast, plasma 17-hydroxyprogesterone levels were normal in only 12{\%} of the patients. Serum 3α-diol G levels correlated well with 24-h urinary 17-ketosteroid excretion (r = 0.75) and plasma 17-hydroxyprogesterone (r = 0.77), androstenedione (r = 0.84), and testosterone (r = 0.93) levels. The serum 3α-diol G levels were not significantly different in the women with the salt-losing form and those with the simple virilizing form. However, they were significantly lower (P<0.05) in the women with normal menses compared to those with abnormal menses. This finding underscores the validity of serum 3α-diol G measurements as indicators of androgen production and metabolism in women. The excellent correlation between the serum 3α-diol G levels and standard measures of control indicates that the former measurement may be a useful adjunct in the management of women with congenital adrenal hyperplasia.",
author = "Reiner, {B. J.} and Donohoue, {P. A.} and Migeon, {C. J.} and Gary Berkovitz",
year = "1989",
month = "1",
day = "1",
language = "English",
volume = "69",
pages = "105--109",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Serum 3α-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy

AU - Reiner, B. J.

AU - Donohoue, P. A.

AU - Migeon, C. J.

AU - Berkovitz, Gary

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Serum 3α-androstanediol glucuronide (3α-diol G) measurements may indicate the extent of androgen metabolism and action in target tissues. To test this supposition we measured serum 3α-diol G concentrations in 23 women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, including 13 with the salt-losing and 10 with the simple virilizing form, while they were receiving glucocorticoid and, in some cases, mineralocorticoid therapy. Their mean age was 28.3 yr (range, 17.9-38.7 yr). Twenty-four-hour urinary 17-ketosteroid excretion, plasma androstenedione and testosterone levels, and serum 3α-diol G levels were measured during the follicular phase. The values were within or below the normal range in 87%, 78%, 70%, and 91% of the patients, respectively. By contrast, plasma 17-hydroxyprogesterone levels were normal in only 12% of the patients. Serum 3α-diol G levels correlated well with 24-h urinary 17-ketosteroid excretion (r = 0.75) and plasma 17-hydroxyprogesterone (r = 0.77), androstenedione (r = 0.84), and testosterone (r = 0.93) levels. The serum 3α-diol G levels were not significantly different in the women with the salt-losing form and those with the simple virilizing form. However, they were significantly lower (P<0.05) in the women with normal menses compared to those with abnormal menses. This finding underscores the validity of serum 3α-diol G measurements as indicators of androgen production and metabolism in women. The excellent correlation between the serum 3α-diol G levels and standard measures of control indicates that the former measurement may be a useful adjunct in the management of women with congenital adrenal hyperplasia.

AB - Serum 3α-androstanediol glucuronide (3α-diol G) measurements may indicate the extent of androgen metabolism and action in target tissues. To test this supposition we measured serum 3α-diol G concentrations in 23 women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, including 13 with the salt-losing and 10 with the simple virilizing form, while they were receiving glucocorticoid and, in some cases, mineralocorticoid therapy. Their mean age was 28.3 yr (range, 17.9-38.7 yr). Twenty-four-hour urinary 17-ketosteroid excretion, plasma androstenedione and testosterone levels, and serum 3α-diol G levels were measured during the follicular phase. The values were within or below the normal range in 87%, 78%, 70%, and 91% of the patients, respectively. By contrast, plasma 17-hydroxyprogesterone levels were normal in only 12% of the patients. Serum 3α-diol G levels correlated well with 24-h urinary 17-ketosteroid excretion (r = 0.75) and plasma 17-hydroxyprogesterone (r = 0.77), androstenedione (r = 0.84), and testosterone (r = 0.93) levels. The serum 3α-diol G levels were not significantly different in the women with the salt-losing form and those with the simple virilizing form. However, they were significantly lower (P<0.05) in the women with normal menses compared to those with abnormal menses. This finding underscores the validity of serum 3α-diol G measurements as indicators of androgen production and metabolism in women. The excellent correlation between the serum 3α-diol G levels and standard measures of control indicates that the former measurement may be a useful adjunct in the management of women with congenital adrenal hyperplasia.

UR - http://www.scopus.com/inward/record.url?scp=0024403761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024403761&partnerID=8YFLogxK

M3 - Article

C2 - 2732292

AN - SCOPUS:0024403761

VL - 69

SP - 105

EP - 109

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -